Evolving Drug Regulation: Harmonization, RWE, Patient-Centricity
Received Date: Aug 01, 2025 / Published Date: Aug 29, 2025
Abstract
Drug regulatory affairs are witnessing significant evolution characterized by international harmonization, the integration of real world evidence, and patient-centric approaches. Regulatory agencies are adopting adaptive pathways, advanced technologies like AI/ML,andspecialized frameworks for novel therapies. Post-market surveillance and robust data governance are crucial for ensuring ongoing safety and efficacy. These shifts aim to expedite access to safe and effective medicines globally while maintaining rigorous scientific standards.
Citation: Zahra DF (2025) Evolving Drug Regulation: Harmonization, RWE, Patient-Centricity. Int J Res Dev Pharm L Sci 11: 291.
Copyright: 漏 2025 Dr. Fatima Zahra This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted聽use, distribution and reproduction in any medium, provided the original author and source are credited
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 344
- [From(publication date): 0-0 - Apr 05, 2026]
- Breakdown by view type
- HTML page views: 294
- PDF downloads: 50
